Efficacy of lamivudine in patients with hepatitis B e antigen- negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B

Hepatology

Volumn 29, Issue 3, 1999, Pages 889-896

  Tassopoulos, Nicolaos C ^a   Volpes, Riccardo ^b   Pasture, Giuseppe ^c   Heathcote, Jenny ^d   Buti, Maria ^e   Goldin, Robert D ^f   Hawley, Sasha ^g   Barber, Judy ^g   Condreay, Lynn ^h   Gray, D Fraser ^g  

^a Western Attica General Hospital   (Greece)

^b SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^c POLICLINICO   (Italy)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f ST MARY S HOSPITAL   (United Kingdom)

^g GLAXOSMITHKLINE   (United Kingdom)

^h GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINO ACID; DNA DIRECTED DNA POLYMERASE ALPHA; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS B; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033012793     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290321     Document Type: Article

References (13)

1. The World Health Report. WHO 1998.
2. Realdi G, Alberti A, Rugge M, Bortolotti F, Tigoli AM, Tremolada F, Rual A. Seroconversion from hepatitis B e antigen to anti HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-199.
3. Hoofnagle JH, Dusheiko GM, Seef LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B . hepatitis. Ann Intern Med 1981;94:744-748.
4. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, DNA viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs. anti-HBe positive carriers of hepatitis B virus. HEPATOLOGY 1983;3:656-662.
5. Lok AS, Hadziyannis S, Weller IV, Karvountzis MV, Monjardino J, Karayiannis P, Montano L, et al. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection. Gut 1984;25:1283-1287.
6. Brunetto MR, Stemler M, Schodel F, Will H, Ottobrelli A, Rizzetto M, Verme G, et al. Identification of HBV variants which cannot produce pre-core derived HBe Ag and may be responsible for severe hepatitis. Ital J Gastroenterol 1989;21:151-154.
7. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of e antigen in patients with chronic HBV infection. Lancet 1989;2(8663):588-591.
8. Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo P, Capra G, Randone A, et al. Hepatitis B virus unable to secrete e Antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993;105:845-850.
9. Laras A, Koskinas J, Avgidis K, Hadziyannis SJ. Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J Viral Hepatitis 1998;5:241-248.
10. Brunetto MR, Olivieri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, et al. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e Antigen. HEPATOLOGY 1989; 10:198-202.
11. Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. HEPATOLOGY 1988;8:493-496.
12. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294-298.
13. Hadziannis SJ. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepatitis 1995;1:7-36.